NEW DELHI: The Nifty Pharma index was trading 1.49 per cent down at 8,828 around 11:30 am (IST) with all components in the red.
Biocon (down 5.25 per cent) plunged the most in the index on reports of USFDA observations of the company’s Bangalore facility.
Reuters reported the company saying that its Bangalore sterile drug product facility has got seven observations from USFDA and six observations from the European regulator.
Cadila Healthcare (down 3.19 per cent), Aurobindo Pharma (down 2.76 per cent) and Piramal Enterprises (down 2.63 per cent) plunged up to 3 per cent.
Cipla (down 1.85 per cent), Lupin (down 1.42 per cent) and Glenmark Pharmaceuticals (down 1.17 per cent) suffered losses of over 1 per cent.
Dr. Reddy’s Laboratories (down 0.89 per cent), Divi’s Laboratories (down 0.40 per cent) and Sun Pharmaceutical Industries (down 0.16 per cent) too were among the losers in the index.
Benchmark NSE Nifty50 index was down 56 points at 10,662, while the BSE Sensex was 123 points down at 35,054.
Among the 50 stocks in the Nifty index, 12 were trading in the green, while 38 were in the red.
